WEBINAR | PMS Progress Overview
Webinar on the Current Status of PMS, EMA Deadlines, Data Quality, and Upcoming Regulatory Developments
August 17, 2026
Webinar on the Current Status of PMS, EMA Deadlines, Data Quality, and Upcoming Regulatory Developments
On 30 June, we reached a major regulatory milestone. At Asphalion, we supported some leading international pharmaceutical
As announced by the European Medicines Agency (EMA) during the PMS Info Day held on Tuesday, the
Today, ASPHALION expert Sonia Tejeda is participating in the Product Management Service (PMS) Information Day at the
At Asphalion, we’re excited to be part of key events, conferences, and summits throughout 2026—great opportunities to connect, exchange insights, and collaborate with leaders across healthcare and medical devices.
The European Medicines Agency (EMA) has announced that, as of 1 September 2026, the use of the
The European Medicines Agency (EMA), together with the Heads of Medicines Agencies (HMA) and the European Commission, has published an updated Union List of Critical Medicines (ULCM), effective 12 December 2025.
Una representación de expertos de Asphalion, encabezada por nuestra CEO Núria Romero, asistió la semana pasada a
Search or filter
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
